Schedule 13G ownership disclosure
ACADIA Pharmaceuticals Inc
Security class unavailable · CUSIP: 004225108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,616,613
- Percent of class
- 6.8900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-018610
- Form type
- SC 13G
- Filer
- ACADIA PHARMACEUTICALS INC
- CIK
- CIK 1070494
- Filed
- Feb 12, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership